Protective role of apigenin in cisplatin-induced renal injury
Authors:
- 1 October 2016
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 789, 215-221
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (Grant No. 31572583)
This publication has 17 references indexed in Scilit:
- The Flavonoid Apigenin Ameliorates Cisplatin-Induced Nephrotoxicity through Reduction of p53 Activation and Promotion of PI3K/Akt Pathway in Human Renal Proximal Tubular Epithelial CellsEvidence-Based Complementary and Alternative Medicine, 2015
- An Extract of Rhodobacter sphaeroides Reduces Cisplatin-Induced Nephrotoxicity in MiceToxins, 2013
- An integrative view of the pathophysiological events leading to cisplatin nephrotoxicityCritical Reviews in Toxicology, 2011
- Mechanisms of Cisplatin NephrotoxicityToxins, 2010
- Cisplatin nephrotoxicity: Mechanisms and renoprotective strategiesKidney International, 2008
- Apigenin Blocks Lipopolysaccharide-Induced Lethality In Vivo and Proinflammatory Cytokines Expression by Inactivating NF-κB through the Suppression of p65 PhosphorylationThe Journal of Immunology, 2007
- Mechanistic Basis for Inflammation and Tumor Promotion in Lungs of 2,6-Di-tert-butyl-4-methylphenol-Treated Mice: Electrophilic Metabolites Alkylate and Inactivate Antioxidant EnzymesChemical Research in Toxicology, 2007
- Enhancement by pyrazole of lipopolysaccharide-induced liver injury in mice: Role of cytochrome P450 2E1 and 2A5Hepatology, 2006
- Lipopolysaccharide-induced liver injury in rats treated with the CYP2E1 inducer pyrazoleAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2005
- Cisplatin nephrotoxicitySeminars in Nephrology, 2003